1. Report Introduction

2. Itacitinib Overview in Polycythemia Vera
2.1. Product Detail
2.2. Clinical Development
2.2.1. Clinical Studies
2.2.2. Clinical Trials Information
2.3. Other Development Activities
2.4. Product Profile

3. Competitive Landscape (Marketed Therapies)

4. Competitive Landscape (Late-stage Emerging Therapies)*

5. Itacitinib Market Assessment
5.1. Market Outlook of Itacitinib in Polycythemia Vera
5.2. 7MM Market Analysis
5.2.1. Market Size of Itacitinib in the 7MM for Polycythemia Vera
5.3. Country-wise Market Analysis
5.3.1. Market Size of Itacitinib in the United States for Polycythemia Vera
5.3.2. Market Size of Itacitinib in Germany for Polycythemia Vera
5.3.3. Market Size of Itacitinib in France for Polycythemia Vera
5.3.4. Market Size of Itacitinib in Italy for Polycythemia Vera
5.3.5. Market Size of Itacitinib in Spain for Polycythemia Vera
5.3.6. Market Size of Itacitinib in the United Kingdom for Polycythemia Vera
5.3.7. Market Size of Itacitinib in Japan for Polycythemia Vera

6. SWOT Analysis

7. Analysts' Views

8. Appendix
8.1. Bibliography
8.2. Report Methodology

9. DelveInsight Capabilities

10. Disclaimer

11. About DelveInsight

12. Report Purchase Option

List of Tables
Table 1: Itacitinib, Clinical Trial Description, 2022
Table 2: Itacitinib: General Description
Table 3: Competitive Landscape (Marketed Therapies)
Table 4: Competitive Landscape (Emerging Therapies)
Table 5: Itacitinib (INCB039110) Market Size in the 7MM, in USD million (2019-2032)
Table 6: Itacitinib (INCB039110) Market Size in the United States, in USD million (2019-2032)
Table 7: Itacitinib (INCB039110) Market Size in Germany, in USD million (2019-2032)
Table 8: Itacitinib (INCB039110) Market Size in France, in USD million (2019-2032)
Table 9: Itacitinib (INCB039110) Market Size in Italy, in USD million (2019-2032)
Table 10: Itacitinib (INCB039110) Market Size in Spain, in USD million (2019-2032)
Table 11: Itacitinib (INCB039110) Market Size in the United Kingdom, in USD million (2019-2032)
Table 12: Itacitinib (INCB039110) Market Size in Japan, in USD million (2019-2032)

List of Figures
Figure 1: Market Size of Itacitinib (INCB039110) in the 7MM, in USD million (2019-2032)
Figure 2: Market Size of Itacitinib (INCB039110) in the United States, in USD million (2019-2032)
Figure 3: Market Size of Itacitinib (INCB039110) in Germany, in USD million (2019-2032)
Figure 4: Market Size of Itacitinib (INCB039110) in France, in USD million (2019-2032)
Figure 5: Market Size of Itacitinib (INCB039110) in Italy, in USD million (2019-2032)
Figure 6: Market Size of Itacitinib (INCB039110) in Spain, in USD million (2019-2032)
Figure 7: Market Size of Itacitinib (INCB039110) in United Kingdom, in USD million (2019-2032)
Figure 8: Market Size of Itacitinib (INCB039110) in Japan, in USD million (2019-2032)